<code id='E6122ECDA6'></code><style id='E6122ECDA6'></style>
    • <acronym id='E6122ECDA6'></acronym>
      <center id='E6122ECDA6'><center id='E6122ECDA6'><tfoot id='E6122ECDA6'></tfoot></center><abbr id='E6122ECDA6'><dir id='E6122ECDA6'><tfoot id='E6122ECDA6'></tfoot><noframes id='E6122ECDA6'>

    • <optgroup id='E6122ECDA6'><strike id='E6122ECDA6'><sup id='E6122ECDA6'></sup></strike><code id='E6122ECDA6'></code></optgroup>
        1. <b id='E6122ECDA6'><label id='E6122ECDA6'><select id='E6122ECDA6'><dt id='E6122ECDA6'><span id='E6122ECDA6'></span></dt></select></label></b><u id='E6122ECDA6'></u>
          <i id='E6122ECDA6'><strike id='E6122ECDA6'><tt id='E6122ECDA6'><pre id='E6122ECDA6'></pre></tt></strike></i>

          entertainment

          knowledge

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Medicare Advantage enrollment grows 7.1% to 33.4 million people
          Medicare Advantage enrollment grows 7.1% to 33.4 million people

          PabloMartinezMonsivais/APRoughly33.4millionadultsolderthan65andpeoplewithdisabilitieswereenrolledina

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Yancopoulos of Regeneron works to expand Dupixent success

          GeorgeYancopoulosonthe2024BreakthroughSummitEaststageSTATGeorgeYancopoulosisintouchwithhisteenagesel